Advanced Search

Show simple item record

dc.contributor.authorAbunahlah, Nibal
dc.contributor.authorElawaisi, Anfal
dc.contributor.authorVelibeyoglu, Fatih Mehmet
dc.contributor.authorSancar, Mesut
dc.date.accessioned2021-05-15T12:41:52Z
dc.date.available2021-05-15T12:41:52Z
dc.date.issued2018
dc.identifier.issn2210-7703
dc.identifier.issn2210-7711
dc.identifier.urihttps://doi.org/10.1007/s11096-017-0585-5
dc.identifier.urihttps://hdl.handle.net/20.500.12939/865
dc.descriptionWOS:000430990800007en_US
dc.descriptionPubMed: 29380236en_US
dc.description.abstractBackground Drug-related problems (DRPs) interfere with patient optimal therapeutic outcomes and may be associated with higher morbidity, mortality and healthcare expenditures. Objective This study aimed to identify DRPs and their causes in a Turkish hospital. Setting Bakirkoy Dr. Sadi Konuk Teaching and Research Hospital, Internal Medicine Ward, Istanbul, Turkey. Method Cross-sectional study included a total of 100 patients. Patient demographics, medications, and history were evaluated. Data regarding recent medications were analyzed by two clinical pharmacists and an Internal Medicine physician. The DRPs were identified via V7.0 PCNE classification. Lexicomp(A (R)) was used to assess the drug-drug interactions. UpToDate(A (R)) recommendations and national guidelines were applied in the assessment of compliance with approved medication procedures. Main outcome measures Number and causes of the potential DRPs. Results At least one potential DRP was seen in 80% of the patients and 163 potential DRPs were identified (average = 1.6 DRPs/patient). The most common causes of DRPs were errors in drug selection (44.78%), dose selection (27.61%) and medication procedures (21.47%). There were significant correlations (p < 0.05) between DRPs and age (r = 0.4), number of drugs used (r = 0.32), duration of hospitalization (r = 0.25), renal impairment (r = - 0.34) and inflammation (r = 0.31). Conclusion The majority of the patients had DRPs. Patients with renal impairment, inflammation, polypharmacy or an extended hospital stay had a much higher chance of developing DRPs.en_US
dc.language.isoengen_US
dc.publisherSpringeren_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectDose Selectionen_US
dc.subjectDrug-Related Problemen_US
dc.subjectMedication Procedureen_US
dc.subjectRenal Impairmenten_US
dc.subjectTurkeyen_US
dc.titleDrug related problems identified by clinical pharmacist at the internal medicine ward in Turkeyen_US
dc.typearticleen_US
dc.departmentEczacılık Fakültesi, Klinik Eczacılık Bölümüen_US
dc.department-temp[Abunahlah, Nibal; Elawaisi, Anfal] Altinbas Univ, Sch Pharm, Dept Clin Pharm, Istanbul, Turkey; [Velibeyoglu, Fatih Mehmet] Bakirkoy Dr Sadi Konuk Educ & Res Hosp, Dept Internal Med, Istanbul, Turkey; [Sancar, Mesut] Marmara Univ, Sch Pharm, Dept Clin Pharm, Istanbul, Turkeyen_US
dc.contributor.institutionauthorAbunahlah, Nibal
dc.contributor.institutionauthorElawaisi, Anfal
dc.identifier.doi10.1007/s11096-017-0585-5
dc.identifier.volume40en_US
dc.identifier.issue2en_US
dc.identifier.startpage360en_US
dc.identifier.endpage367en_US
dc.relation.journalInternational Journal of Clinical Pharmacyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record